Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heliae is an applied life sciences and biotechnology company focused on developing microalgae-based products for agriculture and nutrition. The company pivoted from biofuel research in 2012 to commercialize microalgae solutions for soil health, crop productivity, and sustainable agriculture. It operates through its Heliae Agriculture division, producing the award-winning PhycoTerra product line, which includes microalgae-based biostimulants that enhance beneficial microbial activity in soil, seeds, and plants, leading to improved nutrient access, water retention, soil structure, germination, growth, and crop yields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heliae.